Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bex

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Gene Therapy|September 7, 1999
Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonographyC Asselin-Paturel, N Lassau, J M Guinebretière, et al.
Journal of Virology|March 1, 1994
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccinesZ R Israel, P F Edmonson, D H Maul, et al.
Bone|June 23, 2004
Bone biomechanical properties in LRP5 mutant miceM P Akhter, D J Wells, S J Short, et al.
Journal of Medical Primatology|November 21, 2000
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigensJ L Heeney, G Koopman, B Rosenwirth, et al.
Journal of Virology|March 1, 1996
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccineS P Mossman, F Bex, P Berglund, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Gene Therapy|September 7, 1999
Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonographyC Asselin-Paturel, N Lassau, J M Guinebretière, et al.
Journal of Virology|March 1, 1994
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccinesZ R Israel, P F Edmonson, D H Maul, et al.
Bone|June 23, 2004
Bone biomechanical properties in LRP5 mutant miceM P Akhter, D J Wells, S J Short, et al.
Journal of Medical Primatology|November 21, 2000
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigensJ L Heeney, G Koopman, B Rosenwirth, et al.
Journal of Virology|March 1, 1996
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccineS P Mossman, F Bex, P Berglund, et al.
Pageof 6